First, insulin can directly or indirectly regulate the production of hepatic IGF-1 [40], and relevant clinical research has confirmed that elevated serum IGF-I levels are linked to a greater risk of renal cancer [6, 7] and that insulin resistance further enhances the above effects [8]. This evidence concerns the gene IGF1 and renal carcinoma.